Fractyl Health News

Fractyl Health to Present New Preclinical Obesity Data From Rejuva Platform at the American Diabetes Association's 84th Scientific Sessions

BURLINGTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (NASDAQ:GUTS) (the "Company"), a metabolic therapeutics company focused on pioneering new approaches for the treatment of obesity and type 2

GlobeNewswireMay 29 06:00

Fractyl Health Presents Preclinical Data From Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva at Digestive Disease Week 2024

Fractyl Health, Inc. (NASDAQ:GUTS) (the "Company"), a metabolic therapeutics company focused on pioneering new approaches for the treatment of obesity and type 2 diabetes (T2D), presented new data fro

BenzingaMay 20 05:04

Fractyl Health Presents Compelling Preclinical Data From Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva at Digestive Disease Week 2024

Fractyl Health, Inc. (NASDAQ:GUTS) (the "Company"), a metabolic therapeutics company focused on pioneering new approaches for the treatment of obesity and type 2 diabetes (T2D), presented new data from its preclinical Rejuva pancreatic gene therapy program as part of an oral presentation (abstract number 4029196) on Sunday, May 19th, at Digestive Disease Week (DDW) 2024 in Washington, D.C.

Globe NewswireMay 20 05:00

Bank of America Securities Reaffirms Their Buy Rating on Fractyl Health, Inc. (GUTS)

TipRanksMay 14 07:56

Earnings Call Summary | Fractyl Health(GUTS.US) Q1 2024 Earnings Conference

The following is a summary of the Fractyl Health, Inc. (GUTS) Q1 2024 Earnings Call Transcript:Financial Performance:Fractyl Health generated revenue from its commercial pilot in Germany in Q1 2024.Re

Futu NewsMay 14 04:08 · Conference Call

Fractyl Health Q1 2024 GAAP EPS $(0.17) Up From $(7.87) YoY, Sales $33.000K Up From $5.000K YoY

Fractyl Health (NASDAQ:GUTS) reported quarterly losses of $(0.17) per share. This is a 97.84 percent increase over losses of $(7.87) per share from the same period last year. The company reported $33

BenzingaMay 13 17:12

Fractyl Health Reports Q1 Results

Seeking AlphaMay 13 16:02

Fractyl Health | 10-Q: Quarterly report

SEC announcementMay 13 15:10 · Announcements

Earnings Flash (GUTS) FRACTYL HEALTH Reports Q1 Revenue $33,000

04:01 PM EDT, 05/13/2024 (MT Newswires) -- Earnings Flash (GUTS) FRACTYL HEALTH Reports Q1 Revenue $33,000

MT NewswiresMay 13 15:01

Fractyl Health 1Q Loss $3.32M >GUTS

Fractyl Health 1Q Loss $3.32M >GUTS

Dow JonesMay 13 15:01

Fractyl Health 1Q Rev $33,000 >GUTS

Fractyl Health 1Q Rev $33,000 >GUTS

Dow JonesMay 13 15:01

Press Release: Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates

Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates Initiation of Remain-1 pivotal study for weight maintenance in patients with obesity after discontinuation of

Dow JonesMay 13 15:00

Fractyl Health Says New Revita Data Show Sustained Weight Loss, Glucose Control in Type 2 Diabetes

Fractyl Health (GUTS) said Monday that six-month follow-up data from its German real-world registry study of Revita in patients with type 2 diabetes showed sustained or improved weight loss and better

MT NewswiresMay 13 10:41

Fractyl Health Presents Clinical Update on Revita German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)

First 14 participants with at least six months of follow up continue to demonstrate sustained improvements in blood glucose and weight with reduction in T2D medication utilization after a single Revita treatment No

GlobeNewswireMay 13 05:00

Fractyl Health to Present at BofA Securities 2024 Health Care Conference

BURLINGTON, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (NASDAQ:GUTS) (the "Company"), a metabolic therapeutics company focused on pioneering new approaches for the treatment of obesity and type 2

GlobeNewswireMay 8 05:00

Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024

Globe NewswireMay 7 05:00

Fractyl Health, Inc.'s (NASDAQ:GUTS) Largest Shareholders Are Private Equity Firms With 52% Ownership, Individual Investors Own 30%

Yahoo FinanceMay 3 07:48

Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting

At DDG, Fractyl Health will present new clinical updates on its ongoing real-world registry study of Revita in patients with T2D in Germany At DDW, Fractyl Health will provide an oral presentation fro

GlobeNewswireApr 30 07:38

Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were lower this morning, with the Nasdaq futures falling by around 0.2% on Wednesday. Shares of Intel Corporation (NASDAQ:INTC) fell sharply in today's pre-market trading after th

BenzingaApr 3 04:36

Fractyl Health Names Adrian Kimber Chief Commercial Officer; Shares Down

Fractyl Health (GUTS) said Tuesday it appointed Adrian Kimber as chief commercial officer. Kimber was previously the global vice president and commercial head of neuromodulation at Biotronik, accordin

MT NewswiresApr 2 15:03